公开(公告)号：US20230331855A1

公开(公告)日：2023-10-19

申请号：US18178086

申请日：2023-03-03

Applicant: KITE PHARMA, INC. ,  AMGEN INC.

Inventor： Jed WILTZIUS ,  Ruben ALVAREZ RODRIGUEZ ,  Alice BAKKER ,  Lawren WU ,  Tara ARVEDSON

IPC: C07K16/28 ,  C07K14/435 ,  C07K14/725 ,  C07K14/705 ,  C12N15/86

CPC classification number: C07K16/2851 ,  C07K14/435 ,  C07K14/7051 ,  C07K14/70517 ,  C07K14/70521 ,  C12N15/86 ,  C07K2317/622 ,  A61K2039/505

Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.

公开(公告)号：US20230124464A1

公开(公告)日：2023-04-20

申请号：US17751586

申请日：2022-05-23

Applicant: Amgen, Inc. ,  Kite Pharma, Inc.

Inventor： Alice BAKKER ,  Lawren WU ,  Tara ARVEDSON ,  Jed J. WILTZIUS ,  Ruben Alvarez RODRIGUEZ

IPC: A61K35/17 ,  C07K16/28 ,  C12N9/12 ,  A61P37/06 ,  A61P35/02 ,  C07K14/725 ,  C07K14/705 ,  C12N15/62 ,  C12N15/85

Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells to FLT3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the FLT3 antigen binding molecules and engineered immune cells.

公开(公告)号：US20160024158A1

公开(公告)日：2016-01-28

申请号：US14776917

申请日：2014-03-14

Applicant: AMGEN INC.

Inventor： Ryan B. CASE ,  Benjamin M. ALBA ,  Alice BAKKER ,  Irwin CHEN ,  Amy N. DUGUAY ,  Monica FLORIO ,  Peng LI ,  Mark Leo MICHAELS ,  Mei-mei TSAI

IPC: C07K14/435 ,  A61K47/48 ,  C07K16/18

CPC classification number: C07K14/435 ,  A61K47/60 ,  C07K14/51 ,  C07K16/18 ,  C07K2319/31

Abstract: The present application is directed to avimers and peptides and various combinations thereof in addition to methods of making and using them.

Abstract translation: 除了制备和使用它们的方法之外，本申请涉及avimers和肽及其各种组合。